RxDoctor Payments Data

Ron Israeli, MD

Plastic Surgery · Great Neck, NYNPI 1396777025

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $32,175 of the $35,470 with a category attached, or 90.7%. TELA Bio, Inc. accounts for 93.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $24,145 and has fallen 93.9% since, to $1,470 in 2025. Among plastic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,470in general payments, 2019–2025

Across 46 payments — averaging $771.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$33K
  • RTI Surgical, Inc$1K
  • AbbVie$522
  • Mentor Worldwide LLC$318
  • Axogen$109
  • Heron Therapeutics, Inc.$33
  • plus $160 from 6 others

What the payments were for

  • Consulting fees$32,17591%
  • Speaking & faculty fees$1,2003%
  • Travel & lodging$2541%
  • Food & beverage$1,8415%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,470 in reported general payments places this provider in the 90th percentile of 363 plastic surgery providers in New York.

See all plastic surgery providers in New York

Medicare billing

Part B allowed, 2024
$138,243
Medicare patients
110
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin11$110

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Great Neck

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →